| Product Code: ETC7920964 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Sartans Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Sartans Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Sartans Market - Industry Life Cycle |
3.4 Latvia Sartans Market - Porter's Five Forces |
3.5 Latvia Sartans Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Latvia Sartans Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Latvia Sartans Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Latvia Sartans Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases such as hypertension and cardiovascular diseases in Latvia |
4.2.2 Growing awareness and adoption of sartans as an effective treatment option for hypertension |
4.2.3 Government initiatives promoting healthcare access and affordability for the population |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and market entry in Latvia |
4.3.2 Competition from alternative hypertension treatment options such as ACE inhibitors |
4.3.3 Price fluctuations and cost pressures in the pharmaceutical industry |
5 Latvia Sartans Market Trends |
6 Latvia Sartans Market, By Types |
6.1 Latvia Sartans Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Sartans Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Latvia Sartans Market Revenues & Volume, By Valsartan, 2021- 2031F |
6.1.4 Latvia Sartans Market Revenues & Volume, By Telmisartan, 2021- 2031F |
6.1.5 Latvia Sartans Market Revenues & Volume, By Losartan, 2021- 2031F |
6.1.6 Latvia Sartans Market Revenues & Volume, By Irbesartan, 2021- 2031F |
6.1.7 Latvia Sartans Market Revenues & Volume, By Azilsartan, 2021- 2031F |
6.1.8 Latvia Sartans Market Revenues & Volume, By Olmesartan, 2021- 2031F |
6.2 Latvia Sartans Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Latvia Sartans Market Revenues & Volume, By Valsartan, 2021- 2031F |
6.2.3 Latvia Sartans Market Revenues & Volume, By Telmisartan, 2021- 2031F |
6.2.4 Latvia Sartans Market Revenues & Volume, By Losartan, 2021- 2031F |
6.2.5 Latvia Sartans Market Revenues & Volume, By Irbesartan, 2021- 2031F |
6.2.6 Latvia Sartans Market Revenues & Volume, By Azilsartan, 2021- 2031F |
6.2.7 Latvia Sartans Market Revenues & Volume, By Olmesartan, 2021- 2031F |
6.3 Latvia Sartans Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Latvia Sartans Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Latvia Sartans Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.3.4 Latvia Sartans Market Revenues & Volume, By Others, 2021- 2031F |
7 Latvia Sartans Market Import-Export Trade Statistics |
7.1 Latvia Sartans Market Export to Major Countries |
7.2 Latvia Sartans Market Imports from Major Countries |
8 Latvia Sartans Market Key Performance Indicators |
8.1 Prescription market share of sartans compared to other antihypertensive drugs |
8.2 Patient adherence rates to sartan medications |
8.3 Number of healthcare providers trained in prescribing sartans in Latvia |
8.4 Rate of adverse events reported related to sartan usage |
8.5 Market penetration of sartans in rural areas compared to urban areas |
9 Latvia Sartans Market - Opportunity Assessment |
9.1 Latvia Sartans Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Latvia Sartans Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Latvia Sartans Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Latvia Sartans Market - Competitive Landscape |
10.1 Latvia Sartans Market Revenue Share, By Companies, 2024 |
10.2 Latvia Sartans Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here